216 related articles for article (PubMed ID: 23949620)
1. AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease.
Bhol KC; Tracey DE; Lemos BR; Lyng GD; Erlich EC; Keane DM; Quesenberry MS; Holdorf AD; Schlehuber LD; Clark SA; Fox BS
Inflamm Bowel Dis; 2013 Oct; 19(11):2273-81. PubMed ID: 23949620
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
3. Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
Hartman DS; Tracey DE; Lemos BR; Erlich EC; Burton RE; Keane DM; Patel R; Kim S; Bhol KC; Harris MS; Fox BS
J Crohns Colitis; 2016 Jun; 10(6):641-9. PubMed ID: 26802087
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in mice.
Craven B; Zaric V; Martin A; Mureau C; Egan LJ
Inflamm Bowel Dis; 2015 Mar; 21(3):485-95. PubMed ID: 25581824
[TBL] [Abstract][Full Text] [Related]
6. Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice.
Lopetuso LR; Petito V; Cufino V; Arena V; Stigliano E; Gerardi V; Gaetani E; Poscia A; Amato A; Cammarota G; Papa A; Sgambato A; Gasbarrini A; Scaldaferri F
Dig Liver Dis; 2013 Dec; 45(12):1017-21. PubMed ID: 23911613
[TBL] [Abstract][Full Text] [Related]
7. Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis.
Bloemendaal FM; Levin AD; Wildenberg ME; Koelink PJ; McRae BL; Salfeld J; Lum J; van der Neut Kolfschoten M; Claassens JW; Visser R; Bentlage A; D'Haens GRAM; Verbeek JS; Vidarsson G; van den Brink GR
Gastroenterology; 2017 Nov; 153(5):1351-1362.e4. PubMed ID: 28756234
[TBL] [Abstract][Full Text] [Related]
8. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.
Ungaro R; Fukata M; Hsu D; Hernandez Y; Breglio K; Chen A; Xu R; Sotolongo J; Espana C; Zaias J; Elson G; Mayer L; Kosco-Vilbois M; Abreu MT
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1167-79. PubMed ID: 19359427
[TBL] [Abstract][Full Text] [Related]
9. Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Van den Brande JM; Koehler TC; Zelinkova Z; Bennink RJ; te Velde AA; ten Cate FJ; van Deventer SJ; Peppelenbosch MP; Hommes DW
Gut; 2007 Apr; 56(4):509-17. PubMed ID: 17082252
[TBL] [Abstract][Full Text] [Related]
10. Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis.
Darsigny M; St-Jean S; Boudreau F
Inflamm Bowel Dis; 2010 Oct; 16(10):1739-50. PubMed ID: 20848487
[TBL] [Abstract][Full Text] [Related]
11. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
12. Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis.
Lenzen H; Qian J; Manns MP; Seidler U; Jörns A
J Mol Med (Berl); 2018 Aug; 96(8):831-843. PubMed ID: 29967942
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.
Wang X; Yan J; Wang L; Pan D; Xu Y; Wang F; Sheng J; Li X; Yang M
Theranostics; 2020; 10(23):10808-10822. PubMed ID: 32929381
[No Abstract] [Full Text] [Related]
14. AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial.
Harris MS; Hartman D; Lemos BR; Erlich EC; Spence S; Kennedy S; Ptak T; Pruitt R; Vermeire S; Fox BS
J Crohns Colitis; 2016 Jun; 10(6):631-40. PubMed ID: 26822613
[TBL] [Abstract][Full Text] [Related]
15. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rats with TNBS-induced colitis.
Clemente TR; Dos Santos AN; Sturaro JN; Gotardo EM; de Oliveira CC; Acedo SC; Caria CR; Pedrazzoli J; Ribeiro ML; Gambero A
Scand J Gastroenterol; 2012 Sep; 47(8-9):943-50. PubMed ID: 22630819
[TBL] [Abstract][Full Text] [Related]
16. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
18. Partial normalization of pubertal timing in female mice with DSS colitis treated with anti-TNF-α antibody.
Deboer MD; Steinman J; Li Y
J Gastroenterol; 2012 Jun; 47(6):647-54. PubMed ID: 22322660
[TBL] [Abstract][Full Text] [Related]
19. TNF-α-induced down-regulation of CDX2 suppresses MEP1A expression in colitis.
Coskun M; Olsen AK; Holm TL; Kvist PH; Nielsen OH; Riis LB; Olsen J; Troelsen JT
Biochim Biophys Acta; 2012 Jun; 1822(6):843-51. PubMed ID: 22326557
[TBL] [Abstract][Full Text] [Related]
20. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-α expression.
Takagi T; Naito Y; Mizushima K; Akagiri S; Suzuki T; Hirata I; Omatsu T; Handa O; Kokura S; Ichikawa H; Yoshikawa T
Dig Dis Sci; 2010 Oct; 55(10):2797-804. PubMed ID: 20094779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
